Answers are grounded in this paper and cite their sources.
This study aims to analyze the relationship between the duration of two-month injectable contraceptive use and menstrual cycle disorders among long-term users at PMB Neneng Mahfuzah. The article was developed from processed research data using an observational analytic design with a cross-sectional approach. The respondents consisted of 30 long-term users of two-month injectable contraception. The independent variable was the duration of two-month injectable contraceptive use, categorized as less than 1 year and 1 year or more, while the dependent variable was menstrual cycle disorders. Univariate analysis was used to describe respondent characteristics and variable distributions, followed by bivariate analysis using the Pearson Chi-Square test and risk estimation. The results showed that 60.0% of respondents had used two-month injectable contraception for 1 year or more, while 56.7% experienced menstrual cycle disorders. Cross-tabulation showed that 77.8% of respondents in the 1 year or more usage group experienced cycle disorders, compared with only 25.0% in the less than 1 year group. Statistical analysis demonstrated a significant relationship between the duration of two-month injectable contraceptive use and menstrual cycle disorders (χ²=8.571; p=0.003), with an odds ratio of 10.50. These findings highlight the importance of continuous counseling, monitoring, and education for users of two-month injectable contraception.
No takes yet. Share an insight, caveat, or question.
Maisyarah et al. (2026) studied this question.
Synapse has enriched 4 related papers. Consider them for comparative context: